Clinical trial
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
NCT03089281
Study timeline
Study start (actual)2017-08-01Date precision: day
Registry last updated2022-04-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureverified · MONDO: heart failure
Interventions
CRT-DDEVICE
Sponsors & collaborators
Boston Scientific Corporationlead sponsor
Mapped research locations
AtlantaGeorgia, United States2BerlinGermany2LilleFrance2HoustonTexas, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1San AntonioTexas, United States1MadridSpain1LondonUnited Kingdom1BirminghamAlabama, United States1ColumbusOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03089281 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.